A milestone for the global cannabis industry as STADA, in partnership with MediPharm, forged the way as a large pharmaceutical company. commercializing medical cannabis products. The partnership involves MediPharm Labs. Company Officials say the MediPharm Labs GPM pharmaceutical-quality cannabis production and, combined with STADA’s 125-year heritage and experienced marketing and sales platform, will meet the growing demand of the medical cannabis market. Under the terms of the exclusive partnership, MediPharm will supply GMP certified medical cannabis products to STADA, as well as manufacturing, logistics, and regulatory support. STADA will be responsible for commercializing the cannabis products, initially in Germany. The partnership also signals MediPharm’s entry into the global pharmaceutical industry within a major European market.
Mmp News Author, Medical Marijuana Program Connection, 10/05/2020 06:21:43